MEEDER ASSET MANAGEMENT INC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$3,000
-25.0%
5970.0%0.00%
Q3 2021$4,000
-33.3%
5970.0%0.00%
Q2 2021$6,0000.0%5970.0%0.00%
Q1 2021$6,000
-70.0%
597
-73.8%
0.00%
-100.0%
Q4 2020$20,000
-64.9%
2,277
-53.6%
0.00%0.0%
Q3 2020$57,000
-58.4%
4,911
-2.6%
0.00%
-55.6%
Q2 2020$137,000
+2640.0%
5,042
+540.7%
0.01%
Q1 2020$5,000
-72.2%
787
-84.0%
0.00%
-100.0%
Q1 2019$18,000
-69.5%
4,933
-66.5%
0.00%
-80.0%
Q4 2018$59,000
+353.8%
14,718
+522.6%
0.01%
+400.0%
Q3 2018$13,000
-99.3%
2,364
+404.1%
0.00%
Q2 2018$1,838,000
+183700.0%
469
+189.5%
0.00%
Q1 2018$1,000
-50.0%
162
-69.7%
0.00%
Q4 2017$2,000
-50.0%
534
-23.5%
0.00%
Q3 2017$4,000
-60.0%
698
-45.8%
0.00%
-100.0%
Q2 2017$10,000
+11.1%
1,2890.0%0.00%0.0%
Q1 2017$9,000
+80.0%
1,289
+62.8%
0.00%
Q4 2016$5,0007920.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders